Yonghao Xu, Yin Xi, Shuijiang Cai, Yuheng Yu, Sibei Chen, Weijie Guan, Weibo Liang, Hongkai Wu, Weiqun He, Xilong Deng, Yuanda Xu, Rong Zhang, Manshu Li, Jieyi Pan, Zhenting Liang, Ya Wang, Shaofeng Kong, Xiaoqing Liu, Zheng Lv, Yimin Li
BACKGROUND: Venovenous extracorporeal membrane oxygenation (VV-ECMO) has been demonstrated to be effective in treating patients with virus-induced acute respiratory distress syndrome (ARDS). However, whether the management of ECMO is different in treating H1N1 influenza and coronavirus disease 2019 (COVID-19)-associated ARDS patients remains unknown. METHODS: This is a retrospective cohort study. We included 12 VV-ECMO-supported COVID-19 patients admitted to The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Eighth People's Hospital, and Wuhan Union Hospital West Campus between January 23 and March 31, 2020...
October 31, 2023: J Intensive Med